(Q46046635)

19 December 2017

MDMA

0 references

title

Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective (English)

1 reference

19 December 2017

1 reference

Krista Lisdahl Medina

series ordinal

1

1 reference

19 December 2017

Paula K Shear

series ordinal

2

1 reference

19 December 2017

Kevin Corcoran

series ordinal

3

1 reference

19 December 2017

publication date

1 October 2005

1 reference

19 December 2017

Journal of the International Neuropsychological Society

published in

1 reference

19 December 2017

volume

11

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

753-765

1 reference

19 December 2017

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Memory impairment in abstinent MDMA ("Ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Neuropsychological executive functioning in children at elevated risk for alcoholism: findings in early adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Reading level attenuates differences in neuropsychological test performance between African American and White elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Specific memory deficits in ecstasy users? The results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Increasing MDMA use among college students: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Reliability of alcohol abusers' self-reports of drinking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Auditory verbal learning in drug-free Ecstasy polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

Demographically corrected norms for the California Verbal Learning Test

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties

1 reference

https://api.crossref.org/works/10.1017%2FS1355617705050915

7 January 2021

10.1017/S1355617705050915

Identifiers

DOI

0 references

1 reference

19 December 2017